Its COVID-19 vaccine, developed in collaboration with Oxford University, has been recalled worldwide after the drugmaker admitted in a US court in February about its potential side effects.
(TTS), a rare blood clotting disorder.
AstraZeneca voluntarily withdrew “market authorization” of its Covid vaccine, sold as Covishield in India and Vaxzevri in Europe, the Telegraph reported.
Although it can no longer be used in the EU, the company said it would begin a withdrawal from the global market.
Anurag Aggarwal, dean of the Trivedi School o Biosciences at Ashoka University, told IANS, “It is no longer a useful vaccine.The virus has changed. The risk-benefit is currently against its further use."
“In India, with severe Covid currently becoming less common, possibly due to a combination of hybrid and herd immunity, the decision to vaccinate with the AstraZeneca vaccine should be made after discussing the potential risks and benefits. This is especially true for younger and The same is true for younger at-risk individuals,” said Lancelot Pinto, consultant pulmonologist and epidemiologist, P. D. Hinduj Hospital and MRC, Mumbai.The company, which is credited with saving more than six million lives during the recent Covid-19 pandemic, "in a legal document submitted to the High Court in February, admitted that its Covid vaccine 'in very rare cases' , may cause TTS'," said the report.
TTS is a rare side effect that can cause people to have blood clots and low platelet counts in the blood and has been linked to at least 81 deaths in the UK as well as hundreds of serious injuries.
Lancelot told IANS that TTS is "probably caused by an adenovirus vector".
"A systematic review including studies conducted up to August 2021 found 16 reported cases worldwide. It is thought to occur in 2 per 100,000 people aged 60 years or older who were vaccinated with AstraZeneca, 60 "For every 100,000 people under the age of 20, 2-3 were vaccinated with the AstraZeneca vaccine." Added.
Importantly, the doctor said that “side effects generally appear within a few weeks of vaccination, and are more common after the first dose”.According to modeling estimates, Covid vaccination saved 14.4-19.8 million deaths in the first year, reducing deaths by 63 percent.
Meanwhile, AstraZeneca said in a statement that the vaccine had been withdrawn for "commercial reasons". It said that with multiple Covid variants and related vaccines, “there is a surplus of updated vaccines available”.
(TTS), a rare blood clotting disorder.
AstraZeneca voluntarily withdrew “market authorization” of its Covid vaccine, sold as Covishield in India and Vaxzevri in Europe, the Telegraph reported.
Although it can no longer be used in the EU, the company said it would begin a withdrawal from the global market.
Anurag Aggarwal, dean of the Trivedi School o Biosciences at Ashoka University, told IANS, “It is no longer a useful vaccine.The virus has changed. The risk-benefit is currently against its further use."
“In India, with severe Covid currently becoming less common, possibly due to a combination of hybrid and herd immunity, the decision to vaccinate with the AstraZeneca vaccine should be made after discussing the potential risks and benefits. This is especially true for younger and The same is true for younger at-risk individuals,” said Lancelot Pinto, consultant pulmonologist and epidemiologist, P. D. Hinduj Hospital and MRC, Mumbai.The company, which is credited with saving more than six million lives during the recent Covid-19 pandemic, "in a legal document submitted to the High Court in February, admitted that its Covid vaccine 'in very rare cases' , may cause TTS'," said the report.
TTS is a rare side effect that can cause people to have blood clots and low platelet counts in the blood and has been linked to at least 81 deaths in the UK as well as hundreds of serious injuries.
Lancelot told IANS that TTS is "probably caused by an adenovirus vector".
"A systematic review including studies conducted up to August 2021 found 16 reported cases worldwide. It is thought to occur in 2 per 100,000 people aged 60 years or older who were vaccinated with AstraZeneca, 60 "For every 100,000 people under the age of 20, 2-3 were vaccinated with the AstraZeneca vaccine." Added.
Importantly, the doctor said that “side effects generally appear within a few weeks of vaccination, and are more common after the first dose”.According to modeling estimates, Covid vaccination saved 14.4-19.8 million deaths in the first year, reducing deaths by 63 percent.
Meanwhile, AstraZeneca said in a statement that the vaccine had been withdrawn for "commercial reasons". It said that with multiple Covid variants and related vaccines, “there is a surplus of updated vaccines available”.
